AG-E600 repelling agents have been evaluated by industry regulators and found to be safe and effective for use in nonwoven medical products. They are based on AGC’s patented short-chain C6 polymerization technology, which is nontoxic and does not break down to form PFOA or Perfluorooctane sulfonate (PFOS). In addition, AG-E600 is alkylphenol ethoxylate (APEO) -free and does not contain longer chain length perfluorocarboxylic acids (PFCAs) or their precursors.* (*Levels at detectable limits.)
AG-E600 is nonflammable, provides excellent alcohol/oil repellency and water resistance for polypropylene nonwovens, and has high compatibility with auxiliary agents. Medical products formulated with AG-E600 maintain their repelling performance through repeated washings.
“As the first fluorochemical company to convert its entire PFC product line to C6, AGC leads the U.S. EPA stewardship program,” said Tim Johnson, AGC business manager. “When AG-E600 repelling agents are used in medical nonwovens, manufacturers and end-users are assured of high-performance, sustainable products.”